Human Immunodeficiency Virus-Associated Nephropathy in Pregnancy

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Human immunodeficiency virus (HIV)-associated nephropathy typically leads to endstage renal disease requiring dialysis within 3–4 months. This report describes the prenatal course of a patient with HIV-associated nephropathy requiring dialysis during pregnancy. Case: A 23-year-old nulliparous, black female presented at 13 weeks gestation with a history of HIV-associated nephropathy and anemia. She had a CD4 count of 350/mm3, a total urinary protein of 1.7 g/day, and a serum creatinine of 4.8 mg/dl. The patient was begun on zidovudine, 500 mg daily, and erythropoietin, 4,000 units weekly. At 23 weeks gestation, when she developed hypertension, a total urinary protein of 3.4 g/day, and a serum creatinine of 4.4 mg/dl, she was hospitalized. Her renal function continued to deteriorate, requiring hemodialysis. At 29-4/7 weeks, she developed preterm labor, for which she was placed on indomethacin. Four days later, at 30 weeks gestation, she delivered a viable male infant. Conclusion: HIV-associated nephropathy during pregnancy can be successfully managed with hemodialysis. © 1996, Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Eriksen, N. L., & Mastrobattista, J. M. (1996). Human Immunodeficiency Virus-Associated Nephropathy in Pregnancy. Infectious Diseases in Obstetrics and Gynecology, 4(2), 89–91. https://doi.org/10.1155/S1064744996000191

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free